Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...
Ankylosing Spondylitis is a type of arthritis that mainly affects the back, by causing inflammation and stiffness in your spine. Also called as Bechterew disease, ankylosing spondylitis usually starts ...
Please provide your email address to receive an email when new articles are posted on . Patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis share comparable disease burden ...
Please provide your email address to receive an email when new articles are posted on . Upadacitinib significantly reduced signs and symptoms of both ankylosing spondylitis and nonradiographic axial ...
Novartis' phase III PREVENT trial of Cosentyx in patients with nr-axSpA meets primary endpoint: Basel Wednesday, November 13, 2019, 09:00 Hrs [IST] Novartis, a leader in rheumatol ...
Ankylosing spondylitis is a long term painful disease that affects the spine, bones, muscles and ligaments that connect bones. There is presence of joint pain and inflammation akin to arthritis in ...
When you have ankylosing spondylitis (AS), an inflammatory disease that causes pain and stiffness in your lower back and spine, it’s important to stay as physically active as possible. That may sound ...
If someone has been diagnosed with ankylosing spondylitis, it is essential to monitor heart health and manage symptoms with immediate medical care. Ankylosing spondylitis (AS) is a chronic ...
NEW YORK (Reuters Health), Dec 28 - Ankylosing spondylitis increases the risk of periodontal disease, German researchers report in the January issue of Annals of the Rheumatic Diseases. Lead author Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results